Ziath Supports Food Poverty Charity
Ziath, a manufacturer of imagers for reading 2D barcoded sample tubes which are frequently used for processing Covid-19 samples, has announced support for their local food bank charity in Cambridge, UK. Famous as a centre of elite learning and high-tech industry, Cambridge also has areas of high social deprivation.
To provide support for people with reduced household incomes struggling to feed their children, who would normally receive free school meals, Ziath will make a £5000 donation to its local food poverty relief charity - the Cambridge City Foodbank.
Neil Benn, Managing Director of Ziath commented: “Our company has been working hard to build sample tracking devices for Covid-19 screening programmes around the world. We are lucky that our business is in a sector that has benefi ted during the crisis, but we are mindful of the many thousands of people who have been furloughed on reduced incomes, or lost their jobs completely, who are struggling to feed their families. We wanted to help in our own small way and chose the Cambridge City Foodbank for its valuable work supporting vulnerable families on low incomes across the city.”
Margaret Saner, CEO, Cambridge City Foodbank, commented: “Cambridge City Foodbank is enormously grateful for this generous donation from Ziath. All monetary donations to the Foodbank support
us to run our existing operations, and also help us plan ahead and commit to further sustainable projects that have a lasting impact for those in need in our community. This year, as individuals and families in the city have been heavily impacted by the coronavirus pandemic, we’ve seen rising numbers of people being referred to the food bank. We saw an 8% increase in referrals to Cambridge City Foodbank from March to July 2020, representing a 23% increase in the number of people the Foodbank fed, compared with the same time in the previous year. This includes a 28% increase in the number of children fed by the Foodbank.”
Steve Knight, Commercial Director at Ziath said: “I urge other companies in Health and Life Sciences, which may have done well during the pandemic, to consider giving something back to their local community.”
Earlier this year - Ziath also made donations to charities that support people who may have experienced Mental Health issues during the earlier hard lockdown at the height of the COVID-19 pandemic.
More information online:
ilmt.co/PL/QPMW 53854pr@reply-direct.com
Neil Benn, MD of Ziath presents charity donation
Addition of CRO Builds Cancer Model Network Support
Pharmatest, a contract research organisation providing clinically predictive preclinical effi cacy services for oncology and skeletal diseases, has joined the global network of Repositive’s directory of preclinical cancer models.
“At Repositive, we are committed to establishing new partnerships with specialist CROs to further enhance and strengthen our world-class offering of preclinical cancer models to biopharmaceutical researchers worldwide,” said Fiona Nielsen, CEO of Repositive. “Our collaboration with Pharmatest will enable us to do just that,” she added.
“We chose to partner with Repositive because of their ground- breaking, compelling platform, which helps to connect key players in the preclinical cancer research fi eld,” said Dr Jukka Rissanen, CEO of Pharmatest. “At Pharmatest, we have unique expertise in the fi eld of bone metastases that we want to be able to share as widely as possible and collaborating with Repositive seems like a great way to do this.”
54018pr@reply-direct.com
Finance Terms could Facilitate Reach of Proton Therapy
Next-generation proton therapy systems developer Advanced Oncotherapy has announced a partnership agreement with asset fi nancing partner DiaMedCare AG that will enable easier access to the Company’s LIGHT system by reducing the need for large initial upfront payments from customers.
The partnership agreement will cover projects in Europe and the United States, in line with the Company’s aim to democratise proton beam therapy by deploying LIGHT systems in smaller clinics and urban environments compared with other systems on the market that require large installation sites and signifi cant shielding.
Under the terms of the partnership agreement, DiaMedCare will acquire LIGHT systems and lease them back to the Company’s customers that are commissioning the LIGHT system for oncology treatments. In addition, DiaMedCare will also be able to bridge manufacturing costs until delivery of the LIGHT system to prospective buyers.
Kreske Nickelsen, Partner at DiaMedCare said: “Today, legacy proton therapy systems are usually associated with high upfront capital costs that can introduce a signifi cant hurdle to adoption, particularly for many smaller treatment centres. DiaMedCare’s tailor-made lease fi nancing solutions for Advanced Oncotherapy’s customers will eliminate large upfront payments for the system and will make proton therapy more accessible to local, smaller hospitals.”
Nicolas Serandour, CEO of Advanced Oncotherapy added: “We are pleased to sign this fl exible fi nancing agreement with such an experienced and specialised partner as DiaMedCare to support future sales of our LIGHT systems. The modularity of the LIGHT system allows Advanced Oncotherapy to offer its customers this unique fi nancing opportunity and enable wider access to the LIGHT system. We believe this partnership will signifi cantly increase our pipeline of sales opportunities and democratise proton beam therapy.”
54055pr@reply-direct.com
Merger Integrates Advanced Therapies Expertise
A strategic CRO merger, which has seen mRNA technologies developer Prolytic successfully integrated into the Kymos Group, has broadened the portfolio offering of services for innovative small and large molecules, generics, biosimilars, antibodies, biomarkers, ADA (anti-drug antibodies), ADC (antibody-drug conjugates), hormones, enzymes and nucleic acids.
“Today’s market wants full-service providers and one-stop- solutions. With this merger we will be able to think globally and act locally, providing our clients with a reliable, trustworthy and much- improved service,” said Dr. Dorothee Krone, managing director at Prolytic. “Small and mid-sized companies feel comfortable working with us. Kymos can help us cover the whole life science cycle and we can now offer a much more diverse range of services than we have ever been able to in the past.”
With this merger, Kymos now has three sites in Europe: in Barcelona (Spain), Ancona (Italy) and Frankfurt (Germany). The Italian site is the result of the 2016 merger with Pharmaprogress SRL. Under the agreement, the company names will remain unchanged. At Prolytic’s German site, the current management will remain in place, while staff numbers and investment equipment are expected to increase.
The European group also aims to expand into the Asia-Pacifi c region, whilst opening up promising new therapeutic areas.
53447pr@reply-direct.com
Huber Kältemaschinenbau AG Announces New French Subsidiary
In the past, Sebastian Geiger has been responsible for pre- and post-sale technical support at the HQ of Huber in Germany, including continuous improvement of processes, fault diagnostics, technical training for users and service technicians. In his new role as a CEO, Sebastian Geiger will share his huge experience and special knowledge in refrigeration, thermodynamics, mechanics and electronics to customers and distributors in France.
Furthermore, our long-standing French sales team under the direction of Philippe Muraro and Dr Olivier Jarreton will continue to be the fi rst consultants for our customers for high-precision temperature control technology.
Huber France Services
Peter Huber Kältemaschinenbau AG continues its international expansion. In early November 2020, Huber opened a new support and service centre based in Illkirch-Graffenstaden, France. The new subsidiary will serve end users and partners in France under the name ‘Huber France Services’.
Located in a modern industrial park near Straßbourg, Huber France Services corporate building includes offi ce and workshop area for repairs, as well as service and storage rooms. Sebastian Geiger, CEO of Huber France Services SASU, is looking forward to the challenges ahead: “We are looking forward to exciting projects with our customers and a good cooperation with our long-term partners in France.”
Due to the current situation, an offi cial inauguration ceremony with guests and the management was not held. Daniel Huber, Chairman, sent his greetings from the headquarters in Germany: “We look forward to serving our French customers even better in the future. For this, Sebastian Geiger has put together a competent and experienced team for consulting, sales and service.” In cooperation with long-term business and service partners, the temperature control technology specialist guarantees nationwide customer service in France and wide parts of the Maghreb states.
More information online:
ilmt.co/PL/BopO 54223pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
